These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

796 related articles for article (PubMed ID: 29673928)

  • 1. Utility of urinary biomarkers as a diagnostic tool for early diabetic nephropathy in patients with type 2 diabetes mellitus.
    Vijay S; Hamide A; Senthilkumar GP; Mehalingam V
    Diabetes Metab Syndr; 2018 Sep; 12(5):649-652. PubMed ID: 29673928
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Performance of urinary neutrophil gelatinase-associated lipocalin, clusterin, and cystatin C in predicting diabetic kidney disease and diabetic microalbuminuria: a consecutive cohort study.
    Zeng XF; Lu DX; Li JM; Tan Y; Li Z; Zhou L; Xi ZQ; Zhang SM; Duan W
    BMC Nephrol; 2017 Jul; 18(1):233. PubMed ID: 28701152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of neutrophil gelatinase-associated lipocalin and cystatin C as early markers of diabetic nephropathy.
    Siddiqi Z; Karoli R; Kaul A; Fatima J; Varshney S; Beg MS
    Ann Afr Med; 2017; 16(3):101-106. PubMed ID: 28671149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel urinary biomarkers in pre-diabetic nephropathy.
    Garg V; Kumar M; Mahapatra HS; Chitkara A; Gadpayle AK; Sekhar V
    Clin Exp Nephrol; 2015 Oct; 19(5):895-900. PubMed ID: 25634253
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urinary RBP and NGAL Levels are Associated with Nephropathy in Patients with Type 2 Diabetes.
    Wu J; Shao X; Lu K; Zhou J; Ren M; Xie X; Liu J; Xu Y; Ding Y; Shen X; Zhu C
    Cell Physiol Biochem; 2017; 42(2):594-602. PubMed ID: 28954270
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessing urinary levels of IL-18, NGAL and albumin creatinine ratio in patients with diabetic nephropathy.
    Sueud T; Hadi NR; Abdulameer R; Jamil DA; Al-Aubaidy HA
    Diabetes Metab Syndr; 2019; 13(1):564-568. PubMed ID: 30641767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative diagnostic utility of different urinary biomarkers during pre-albuminuric stages of non-hypertensive type 2 diabetic nephropathy.
    Mahapatra HS; Kulshreshtha B; Goyal P; Chitkara A; Kumari A; Arora A; Sekhar V; Gupta YP
    Indian J Med Res; 2022 Jul; 156(1):46-55. PubMed ID: 36510897
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Markers of Glomerular and Tubular Damage in the Early Stage of Kidney Disease in Type 2 Diabetic Patients.
    Żyłka A; Dumnicka P; Kuśnierz-Cabala B; Gala-Błądzińska A; Ceranowicz P; Kucharz J; Ząbek-Adamska A; Maziarz B; Drożdż R; Kuźniewski M
    Mediators Inflamm; 2018; 2018():7659243. PubMed ID: 30158836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NGAL and cystatin C: two possible early markers of diabetic nephropathy in young patients with type 1 diabetes mellitus: one year follow up.
    Papadopoulou-Marketou N; Skevaki C; Kosteria I; Peppa M; Chrousos GP; Papassotiriou I; Kanaka-Gantenbein C
    Hormones (Athens); 2015; 14(2):232-40. PubMed ID: 25402375
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of an earlier tubulopathy in diabetic nephropathy among children with normoalbuminuria.
    Hafez MH; El-Mougy FA; Makar SH; Abd El Shaheed S
    Iran J Kidney Dis; 2015 Mar; 9(2):126-31. PubMed ID: 25851291
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes of serum and urine neutrophil gelatinase-associated lipocalin in type-2 diabetic patients with nephropathy: one year observational follow-up study.
    Yang YH; He XJ; Chen SR; Wang L; Li EM; Xu LY
    Endocrine; 2009 Aug; 36(1):45-51. PubMed ID: 19390997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urinary biomarkers of tubular injury to predict renal progression and end stage renal disease in type 2 diabetes mellitus with advanced nephropathy: A prospective cohort study.
    Satirapoj B; Pooluea P; Nata N; Supasyndh O
    J Diabetes Complications; 2019 Sep; 33(9):675-681. PubMed ID: 31227289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urinary neutrophil gelatinase-associated lipocalin in type 2 diabetes: Relation to nephropathy and retinopathy.
    Hosny SS; Bekhet MM; Hebah HA; Mohamed NR
    Diabetes Metab Syndr; 2018 Nov; 12(6):1019-1024. PubMed ID: 29960862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of early biomarkers of renal dysfunction in diabetic patients.
    Al-Hazmi SF; Gad HGM; Alamoudi AA; Eldakhakhny BM; Binmahfooz SK; Alhozali AM
    Saudi Med J; 2020 Jul; 41(7):690-697. PubMed ID: 32601635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neutrophil gelatinase-associated lipocalin as an early biomarker of nephropathy in diabetic patients.
    Bolignano D; Lacquaniti A; Coppolino G; Donato V; Fazio MR; Nicocia G; Buemi M
    Kidney Blood Press Res; 2009; 32(2):91-8. PubMed ID: 19321980
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma Neutrophil Gelatinase-Associated Lipocalin as a Marker of Tubular Damage in Diabetic Nephropathy.
    Kim SY; Jeong TD; Lee W; Chun S; Sunwoo S; Kim SB; Min WK
    Ann Lab Med; 2018 Nov; 38(6):524-529. PubMed ID: 30027695
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urinary Neutrophil Gelatinase-Associated Lipocalin (NGAL) as a Marker of Diabetic Nephropathy in Type 1 Diabetic Patients.
    Sisman P; Gul OO; Dirican M; Bal AS; Cander S; Erturk E
    Clin Lab; 2020 Jan; 66(1):. PubMed ID: 32013365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neutrophil Gelatinase-Associated Lipocalin (NGAL) and Kidney Injury Molecule 1 (KIM1) in patients with diabetic nephropathy: a cross-sectional study and the effects of lisinopril.
    Nielsen SE; Schjoedt KJ; Astrup AS; Tarnow L; Lajer M; Hansen PR; Parving HH; Rossing P
    Diabet Med; 2010 Oct; 27(10):1144-50. PubMed ID: 20854382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The changes of serum sKlotho and NGAL levels and their correlation in type 2 diabetes mellitus patients with different stages of urinary albumin.
    Wu C; Wang Q; Lv C; Qin N; Lei S; Yuan Q; Wang G
    Diabetes Res Clin Pract; 2014 Nov; 106(2):343-50. PubMed ID: 25263500
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urinary heme oxygenase-1 as a potential biomarker for early diabetic nephropathy.
    Li Z; Xu Y; Liu X; Nie Y; Zhao Z
    Nephrology (Carlton); 2017 Jan; 22(1):58-64. PubMed ID: 26733347
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 40.